SELVAS Healthcare, Inc.
Financials
Valuation Metrics
SELVAS Healthcare, Inc.'s Market Cap is ₩597B. At end of 2025 it was ₩1496B. Ranked #1660 of 2,421 in KR market (top 69%), #995 of 1,640 on KOSDAQ (top 61%), #66 of 96 in Health Care Equipment & Services (top 69%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 59.72B KRW | KR#1,660/2,421 Sec#66/96 |
| Revenue | 31.69B KRW | KR#2,012/2,421 Sec#64/96 |
| Net Income | 8.70B KRW | KR#1,019/2,421 Sec#28/96 |
| Total Assets | 85.20B KRW | KR#1,900/2,421 Sec#60/96 |
| Net Assets | 75.79B KRW | KR#1,621/2,421 Sec#48/96 |
| Employees | 132 | KR#1,428/2,421 Sec#49/96 |
| Value | ||
| P/E | 6.87x | KR#551/2,421 Sec#11/96 |
| P/B | 0.79x | KR#1,247/2,421 Sec#31/96 |
| PEG | 0.02x | KR#181/2,421 Sec#7/96 |
| P/S | 1.88x | KR#1,775/2,421 Sec#50/96 |
| EV/EBITDA | 37.65x | KR#1,272/2,421 Sec#41/96 |
| FCF Yield | -0.92% | KR—/2,421 Sec—/96 |
| Profitability | ||
| ROE | 11.48% | KR#510/2,421 Sec#21/96 |
| ROA | 10.21% | KR#264/2,421 Sec#13/96 |
| Op. Margin | 4.92% | KR#972/2,421 Sec#40/96 |
| Revenue Growth | 0.04% | KR#1,530/2,421 Sec#74/96 |
| Earnings Growth | 328.64% | KR#155/2,421 Sec#8/96 |
| Financial Health | ||
| Debt Ratio | 12.42% | KR#197/2,421 Sec#12/96 |
| Total Debt | 1.96B KRW | KR#1,913/2,421 Sec#71/96 |
| FCF | -552.0M KRW | KR#1,258/2,421 Sec#37/96 |
| Cash | 2.95B KRW | KR#2,168/2,421 Sec#88/96 |
| Current Ratio | 7.45x | KR#162/2,421 Sec#15/96 |
| Net Debt/EBITDA | -0.63x | KR#460/2,421 Sec#17/96 |
| Performance | ||
| 1Y Return | -42.57% | KR#1,897/2,421 Sec#62/96 |
| 1M Return | -7.20% | KR#1,942/2,421 Sec#65/96 |
| From 52W High | -69.03% | KR#2,171/2,421 Sec#79/96 |
| 1Y MDD | -67.14% | KR#1,844/2,421 Sec#62/96 |
| Trading | ||
| Volume | 78,194 shares | KR#909/2,421 Sec#31/96 |
| Trading Value | 182.2M KRW | KR#1,314/2,421 Sec#53/96 |
| Foreign Own. | 4.17% | KR#1,007/2,421 Sec#33/96 |
| Per Share | ||
| EPS | 338 KRW | KR#1,125/2,421 Sec#33/96 |
| BPS | 2,944 KRW | KR#1,871/2,421 Sec#59/96 |
Company Info
Selvas Healthcare was established in 1999 to develop and sell medical diagnostic devices and visual assistive technology devices, enhancing its technological capabilities through a 2015 merger with Jawon Medical. The company operates two divisions: Accuniq, for body composition analyzers and automatic blood pressure monitors, and Himss, which produces braille information terminals and reading magnifiers for the visually impaired. Leveraging 30 years of technological expertise, Selvas Healthcare is growing as a specialized digital healthcare company, expanding into international markets via partnerships with fitness distribution channels. Selvas Healthcare was established in 2014 and is headquartered in Yuseong-gu, Daejeon.